Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antivirals.
Fukumoto T, Minami T, Moriyama M, Yamada T, Wake T, Kinoshita MN, Fujiwara N, Nakagomi R, Nakatsuka T, Sato M, Enooku K, Nakagawa H, Fujishiro M, Shiina S, Koike K, Tateishi R.
Fukumoto T, et al.
Hepatol Commun. 2022 Sep;6(9):2496-2512. doi: 10.1002/hep4.2010. Epub 2022 May 31.
Hepatol Commun. 2022.
PMID: 35641233
Free PMC article.